Purdue Pharma is a pharmaceutical company that created the drug called OxyContin‚ which is widely credited for having launched the opioid epidemic that has come to affect several Canadian regardless of socioeconomic status. Canada being the world’s second-largest per capita per consumer of opioids behind the United States which is rooted in over-prescribing. The rise of OxyContin was initially thought to be a beneficial one because it was advertised as a pain reliever was produced with a slow-release
Premium Drug Drug addiction Illegal drug trade
fraction of molecules in research and development ultimately become pharmaceutical products. However‚ the rewards of a successful new product can be tremendous generating‚ depending on the therapeutic areas in which the product will be used and the disease it will directed to‚ from millions to billions of dollars of sales annually worldwide. Many pharmaceutical companies are facing a pipeline gap because of the increasing economic burden and uncertainty associated with internal research and development programs
Premium Net present value Discounted cash flow Cash flow
PHARMA-SAYA INNOVATIVE SOLUTIONS‚ INC. Bringing better smiles that build better lives 259 CEU Bldg.‚ Sen. Gil Puyat Ave.‚ Makati City Phils. OUR MOTTO Bringing better smiles that build better lives. OUR MISSION-VISION STATEMENT PSIS is a Philippine company that values one of the most cognizant traits of the Filipino men‚ being gleeful‚ where the connotation that the SMILE is the most powerful weapon and shield of the Filipino started. The company is dedicated to bring better
Free Metro Manila Manila Toothpaste
|OBJECTIVE OF THE STUDY |6 | |3 |NEED TO KNOW PHARMA INDUSTRY |7 | |4 |PHARMA INDUSTRY TODAY |7 | |5 |KEY ISSUE FOR PHARMACEUTICAL
Premium Pharmaceutical industry Pharmacology Generic drug
EQUITY RESEARCH IN BANKING SECTOR Research Project submitted In Part Completion of Masters of Management Studies University of Mumbai By Amit Kanowjia Under the guidance of Mr. Nikesh Ruparel Vidyalankar Institute of Technology Wadala (E)‚ Mumbai – 400 037 JULY 2010 DECLARATION I hereby declare that the project work entitled “Equity Research in Banking Sector “ submitted to “Vidyalankar Institute of Technology‚ wadala(E)‚ Mumbai-400037 “ is a record of an original
Premium Technical analysis Stock market Stock
1) Millenniums Pharmaceuticals strategy basically focused on revolutionizing drug development through the use of new technology during growth phase and making organizational changes during its maturing phase of by making strategic improvements in the organizational structure‚ making alliances‚ outsourcing etc by having vertical integration and moving from upstream to downstream model. In phase 1‚ technology helped the firm leapfrog most other biotechnology firms in the early stage of drug target
Premium Strategic management
analysis and forecasting on the Stock of Bata Shoe company- The market leader in the tannery footwear in Bangladesh. The purpose of this report is to analyze the investment environment and to forecast an expected return on Bata stock. As a proper equity research report it has many parts. The report starts with a very brief overview of Bata Company and the performance of its stock in the past year. This deals with EPS‚ P/E ratio and Historical data and return on Bata stock. After this the report delves
Premium Stock market Financial ratio Economic growth
Bio Pharma Case Analysis Question 1 How should BioPharma have used its production network in 2009? Should any of the plants have been idled? What is the annual cost of your proposal‚ including import duties? As Landgraf’s objective is to design a more cost-effective network (cost minimization problem subject to various capacity constraints)‚ the following production network in 2009 should have been used by BioPharma: *All numbers below are in millions *Total Transportation Cost=SUMPRODUCT
Premium Costs Total cost Variable cost
largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organized nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry is highly fragmented with about 24‚000 players (330 in the organized sector). The top ten companies make up for more than a third of the MARKET Indian pharma companies have a large
Premium Pharmaceutical industry Generic drug Pharmacology
Company Background Square Pharmaceuticals Limited has been a household name in Bangladesh since 1958 when it started its operations as a partnership‚ getting incorporated in 1964 and finally getting listed at the stock exchange in 1995. The company has been in the leading front of innovation‚ and continues to introduce new and better medicines in the market every year. Today the 97% of the demands for medicine in the domestic market is catered to by the local pharmaceuticals company and Square
Premium Financial ratios Financial ratio Revenue